Safer Shot Stock Performance
| SAFS Stock | USD 0.0001 0.00 0.00% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Safer Shot are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Safer Shot has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Safer Shot is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Safer |
Safer Shot Relative Risk vs. Return Landscape
If you would invest 0.01 in Safer Shot on September 30, 2025 and sell it today you would earn a total of 0.00 from holding Safer Shot or generate 0.0% return on investment over 90 days. Safer Shot is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Safer, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Safer Shot Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Safer Shot's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Safer Shot, and traders can use it to determine the average amount a Safer Shot's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| SAFS |
Based on monthly moving average Safer Shot is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Safer Shot by adding Safer Shot to a well-diversified portfolio.
Safer Shot Fundamentals Growth
Safer Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Safer Shot, and Safer Shot fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Safer Pink Sheet performance.
| Return On Asset | -0.5 | |||
| Current Valuation | 67.25 K | |||
| Shares Outstanding | 1.35 M | |||
| Cash And Equivalents | 71 | |||
| Total Debt | 144.93 K | |||
| Book Value Per Share | (0.34) X | |||
| Cash Flow From Operations | (172) | |||
| Earnings Per Share | (0.69) X | |||
| Total Asset | 110.49 K | |||
| Retained Earnings | (3.05 M) | |||
| Current Liabilities | 506 K | |||
About Safer Shot Performance
Assessing Safer Shot's fundamental ratios provides investors with valuable insights into Safer Shot's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Safer Shot is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Safer Shot, Inc., a development stage company, engages in the development, manufacture, marketing, and sale of non-lethal hand held weapons. Safer Shot, Inc. was founded in 1997 and is headquartered in Annapolis, Maryland. SAFER SHOT is traded on PNK Exchange in the United States.Things to note about Safer Shot performance evaluation
Checking the ongoing alerts about Safer Shot for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Safer Shot help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Safer Shot generated a negative expected return over the last 90 days | |
| Safer Shot has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (87.23 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Safer Shot currently holds about 71 in cash with (172) of positive cash flow from operations. |
- Analyzing Safer Shot's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Safer Shot's stock is overvalued or undervalued compared to its peers.
- Examining Safer Shot's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Safer Shot's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Safer Shot's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Safer Shot's pink sheet. These opinions can provide insight into Safer Shot's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Safer Pink Sheet Analysis
When running Safer Shot's price analysis, check to measure Safer Shot's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Safer Shot is operating at the current time. Most of Safer Shot's value examination focuses on studying past and present price action to predict the probability of Safer Shot's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Safer Shot's price. Additionally, you may evaluate how the addition of Safer Shot to your portfolios can decrease your overall portfolio volatility.